Categories: DevelopmentDrugEngineeringTechnology
CTCELLS is a cancer diagnosis and drug development company based on liquid biopsy testing and NK engineering technology
Investors 1
Mentions in press and media 1
| Date | Title | Description |
| 13.02.2025 | TMC names 2025 cohort of cancer treatment innovators | Texas Medical Center Innovation has named more than 50 health care innovators to the fifth cohort of its Accelerator for Cancer Therapeutics (ACT).
The group specializes in immunotherapy, precision drug discovery, monoclonal antibodies, and... |
Reviews 0
